Research Summary
Gene therapy for cardiovascular diseases involves the use of genetic interventions to address underlying issues contributing to heart-related disorders. This therapeutic approach aims to modify or introduce specific genes to improve the function of the cardiovascular system. In the context of cardiovascular diseases, gene therapy may target conditions such as ischemic heart disease, heart failure, or genetic disorders affecting cardiac function. Strategies include enhancing blood vessel formation, promoting cell survival, or modulating the expression of genes associated with cardiac health. Researchers are exploring gene therapy approaches to improve angiogenesis, reduce inflammation, and enhance myocardial function. While gene therapy for cardiovascular diseases is still in the experimental stage, early clinical trials and preclinical studies suggest the potential for novel treatment options to address the complex mechanisms involved in these conditions, offering hope for more effective and targeted interventions in the future.
According to DIResearch's in-depth investigation and research, the global Gene Therapy On Cardiovascular Disease market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Gene Therapy On Cardiovascular Disease include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Human Stem Cells Institute, Orchard Therapeutics etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Gene Therapy On Cardiovascular Disease. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Gene Therapy On Cardiovascular Disease market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Gene Therapy On Cardiovascular Disease market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gene Therapy On Cardiovascular Disease industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Gene Therapy On Cardiovascular Disease Include:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Human Stem Cells Institute
Orchard Therapeutics
Gene Therapy On Cardiovascular Disease Product Segment Include:
Viral Gene Therapy
Non-Viral Gene Therapy
Gene Therapy On Cardiovascular Disease Product Application Include:
Neurological Diseases
Cancer
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Gene Therapy On Cardiovascular Disease Industry PESTEL Analysis
Chapter 3: Global Gene Therapy On Cardiovascular Disease Industry Porter's Five Forces Analysis
Chapter 4: Global Gene Therapy On Cardiovascular Disease Major Regional Market Size and Forecast Analysis
Chapter 5: Global Gene Therapy On Cardiovascular Disease Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Gene Therapy On Cardiovascular Disease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Gene Therapy On Cardiovascular Disease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Gene Therapy On Cardiovascular Disease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Gene Therapy On Cardiovascular Disease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Gene Therapy On Cardiovascular Disease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Gene Therapy On Cardiovascular Disease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Gene Therapy On Cardiovascular Disease Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Gene Therapy On Cardiovascular Disease Market Overview 1.1 Product Definition and Statistical Scope 1.2 Gene Therapy On Cardiovascular Disease Product by Type 1.2.1 Global Gene Therapy On Cardiovascular Disease Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Viral Gene Therapy 1.2.3 Non-Viral Gene Therapy 1.3 Gene Therapy On Cardiovascular Disease Product by Application 1.3.1 Global Gene Therapy On Cardiovascular Disease Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Neurological Diseases 1.3.3 Cancer 1.3.4 Other 1.4 Global Gene Therapy On Cardiovascular Disease Market Revenue Analysis (2019-2030) 1.5 Gene Therapy On Cardiovascular Disease Market Development Status and Trends 1.5.1 Gene Therapy On Cardiovascular Disease Industry Development Status Analysis 1.5.2 Gene Therapy On Cardiovascular Disease Industry Development Trends Analysis 2 Gene Therapy On Cardiovascular Disease Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Gene Therapy On Cardiovascular Disease Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Gene Therapy On Cardiovascular Disease Market Analysis by Regions 4.1 Gene Therapy On Cardiovascular Disease Overall Market: 2023 VS 2024 VS 2030 4.2 Global Gene Therapy On Cardiovascular Disease Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Gene Therapy On Cardiovascular Disease Revenue and Market Share by Region (2019-2024) 4.2.2 Global Gene Therapy On Cardiovascular Disease Revenue Forecast by Region (2025-2030) 5 Global Gene Therapy On Cardiovascular Disease Market Size by Type and Application 5.1 Global Gene Therapy On Cardiovascular Disease Market Size by Type 5.2 Global Gene Therapy On Cardiovascular Disease Market Size by Application 6 North America 6.1 North America Gene Therapy On Cardiovascular Disease Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Gene Therapy On Cardiovascular Disease Market Size by Type 6.4 North America Gene Therapy On Cardiovascular Disease Market Size by Application 6.5 North America Gene Therapy On Cardiovascular Disease Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Gene Therapy On Cardiovascular Disease Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Gene Therapy On Cardiovascular Disease Market Size by Type 7.4 Europe Gene Therapy On Cardiovascular Disease Market Size by Application 7.5 Europe Gene Therapy On Cardiovascular Disease Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Gene Therapy On Cardiovascular Disease Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Gene Therapy On Cardiovascular Disease Market Size by Type 8.4 China Gene Therapy On Cardiovascular Disease Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Gene Therapy On Cardiovascular Disease Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Gene Therapy On Cardiovascular Disease Market Size by Type 9.4 APAC (excl. China) Gene Therapy On Cardiovascular Disease Market Size by Application 9.5 APAC (excl. China) Gene Therapy On Cardiovascular Disease Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Gene Therapy On Cardiovascular Disease Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Gene Therapy On Cardiovascular Disease Market Size by Type 10.4 Latin America Gene Therapy On Cardiovascular Disease Market Size by Application 10.5 Latin America Gene Therapy On Cardiovascular Disease Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Type 11.4 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Application 11.5 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Gene Therapy On Cardiovascular Disease Market Revenue by Key Manufacturers (2020-2024) 12.2 Gene Therapy On Cardiovascular Disease Competitive Landscape Analysis and Market Dynamic 12.2.1 Gene Therapy On Cardiovascular Disease Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Biogen 13.1.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Biogen Gene Therapy On Cardiovascular Disease Product Portfolio 13.1.3 Biogen Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Novartis 13.2.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Novartis Gene Therapy On Cardiovascular Disease Product Portfolio 13.2.3 Novartis Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Gilead Sciences 13.3.1 Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Gilead Sciences Gene Therapy On Cardiovascular Disease Product Portfolio 13.3.3 Gilead Sciences Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Sarepta Therapeutics 13.4.1 Sarepta Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product Portfolio 13.4.3 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Alnylam Pharmaceuticals 13.5.1 Alnylam Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Portfolio 13.5.3 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Amgen 13.6.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Amgen Gene Therapy On Cardiovascular Disease Product Portfolio 13.6.3 Amgen Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Spark Therapeutics 13.7.1 Spark Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Portfolio 13.7.3 Spark Therapeutics Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Akcea Therapeutics 13.8.1 Akcea Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Portfolio 13.8.3 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 bluebird bio 13.9.1 bluebird bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 bluebird bio Gene Therapy On Cardiovascular Disease Product Portfolio 13.9.3 bluebird bio Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Sunway Biotech 13.10.1 Sunway Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Sunway Biotech Gene Therapy On Cardiovascular Disease Product Portfolio 13.10.3 Sunway Biotech Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 SIBIONO 13.11.1 SIBIONO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 SIBIONO Gene Therapy On Cardiovascular Disease Product Portfolio 13.11.3 SIBIONO Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.12 AnGes 13.12.1 AnGes Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 AnGes Gene Therapy On Cardiovascular Disease Product Portfolio 13.12.3 AnGes Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.13 Human Stem Cells Institute 13.13.1 Human Stem Cells Institute Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Portfolio 13.13.3 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.14 Orchard Therapeutics 13.14.1 Orchard Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.14.2 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Portfolio 13.14.3 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Gene Therapy On Cardiovascular Disease Industry Chain Analysis 14.2 Gene Therapy On Cardiovascular Disease Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Gene Therapy On Cardiovascular Disease Typical Downstream Customers 14.4 Gene Therapy On Cardiovascular Disease Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support